These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27436386)

  • 21. [The action of combinations of the nonapeptide polymyxin B with antibiotics on gram-negative bacteria].
    Bairamashvili DI; Zinchenko AA; Maslin DN; Trakhanova MN; Miroshnikov AI
    Antibiot Khimioter; 1988 Aug; 33(8):591-4. PubMed ID: 2848467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance associated with selective decontamination of the digestive tract.
    Webb CH
    J Hosp Infect; 1992 Sep; 22(1):1-5. PubMed ID: 1358943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.
    Petersen PJ; Labthavikul P; Jones CH; Bradford PA
    J Antimicrob Chemother; 2006 Mar; 57(3):573-6. PubMed ID: 16431863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics.
    Yoon SY; Eo SK; Kim YS; Lee CK; Han SS
    Arch Pharm Res; 1994 Dec; 17(6):438-42. PubMed ID: 10319155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria.
    Yin J; Meng Q; Cheng D; Fu J; Luo Q; Liu Y; Yu Z
    Appl Microbiol Biotechnol; 2020 May; 104(9):3771-3780. PubMed ID: 32157424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifaximin--a novel antimicrobial for enteric infections.
    Huang DB; DuPont HL
    J Infect; 2005 Feb; 50(2):97-106. PubMed ID: 15667909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decline of multidrug-resistant Gram negative infections with the routine use of a multiple decontamination regimen in ICU.
    Camus C; Sauvadet E; Tavenard A; Piau C; Uhel F; Bouju P; Letheulle J; Dollo G; Gacouin A; Lavoué S; Le Tulzo Y
    J Infect; 2016 Sep; 73(3):200-9. PubMed ID: 27373765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
    Personne Y; Curtis MA; Wareham DW; Waite RD
    J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy for Gram-negative bacteria: what is the evidence?
    Kmeid JG; Youssef MM; Kanafani ZA; Kanj SS
    Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1355-62. PubMed ID: 24168069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial and antibiotic-modifying activities of three food plants (Xanthosoma mafaffa Lam., Moringa oleifera (L.) Schott and Passiflora edulis Sims) against multidrug-resistant (MDR) Gram-negative bacteria.
    Dzotam JK; Touani FK; Kuete V
    BMC Complement Altern Med; 2016 Jan; 16():9. PubMed ID: 26753836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens.
    Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A
    Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study.
    de Smet AM; Kluytmans JA; Blok HE; Mascini EM; Benus RF; Bernards AT; Kuijper EJ; Leverstein-van Hall MA; Jansz AR; de Jongh BM; van Asselt GJ; Frenay IH; Thijsen SF; Conijn SN; Kaan JA; Arends JP; Sturm PD; Bootsma MC; Bonten MJ
    Lancet Infect Dis; 2011 May; 11(5):372-80. PubMed ID: 21420908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antibacterial and antibiotic-potentiation activities of the methanol extracts from Beilschmiedia acuta, Clausena anisata, Newbouldia laevis and Polyscias fulva against multidrug-resistant Gram-negative bacteria.
    Tankeo SB; Tane P; Kuete V
    BMC Complement Altern Med; 2015 Nov; 15():412. PubMed ID: 26590804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholic acid derivatives: novel antimicrobials.
    Savage PB; Li C
    Expert Opin Investig Drugs; 2000 Feb; 9(2):263-72. PubMed ID: 11060676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
    Poirel L; Jayol A; Nordmann P
    Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.